Protagonist Therapeutics, Inc — Director's Dealing 2021

Sep 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2021-09-21

Reporting Person: PATEL DINESH V PH D (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-21	Common Stock	M	40000	$4.21	Acquired	492158	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-21	Stock Option (right to buy)	$4.21	M	40000	Disposed	2026-04-29	Common Stock (40000)	Direct

Footnotes

F1: Includes an aggregate of 1,014 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2021 and September 9, 2021.

F2: The stock option is vested in full.